We are live on ! Find out more
PFC

Poplar Forest Capital Portfolio holdings

AUM $563M
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+8.43%
3 Year Est. Return
+29.98%
5 Year Est. Return
+205.03%
10 Year Est. Return
+231.64%
AUM
$1.01B
AUM Growth
+$69.3M
Cap. Flow
+$19.7M
Cap. Flow %
1.96%
Top 10 Hldgs %
44.36%
Holding
54
New
5
Increased
23
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$11.6M
2
DNB
Dun & Bradstreet
DNB
+$10.5M
3
RDC
Rowan Companies Plc
RDC
+$10.3M
4
DGX icon
Quest Diagnostics
DGX
+$9.5M
5
C icon
Citigroup
C
+$5.51M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.5M
2
TEL icon
TE Connectivity
TEL
+$12M
3
XRX icon
Xerox
XRX
+$10.2M
4
AA icon
Alcoa
AA
+$8.41M
5
BAC icon
Bank of America
BAC
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 33.31%
2 Technology 14.61%
3 Energy 10.57%
4 Healthcare 10.1%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACM icon
26
Aecom
ACM
$8.78B
$20.2M 2.01%
628,551
+28,490
+5% +$919K
AA icon
27
Alcoa
AA
$11.6B
$19.6M 1.95%
547,369
-256,436
-32% -$8.41M
RS icon
28
Reliance Steel & Aluminium
RS
$20.2B
$15.3M 1.52%
206,897
+43,159
+26% +$3.1M
URS
29
DELISTED
URS CORP
URS
$14.7M 1.46%
321,074
+113,512
+55% +$5.24M
DNB
30
DELISTED
Dun & Bradstreet
DNB
$11M 1.09%
+99,688
New +$10.5M
RDC
31
DELISTED
Rowan Companies Plc
RDC
$10.5M 1.04%
+328,398
New +$10.3M
DGX icon
32
Quest Diagnostics
DGX
$23.3B
$9.52M 0.95%
+162,177
New +$9.5M
DNY
33
DELISTED
DONNELLEY R R & SONS CO
DNY
$9.28M 0.92%
547,367
+47,026
+9% +$798K
PG icon
34
Procter & Gamble
PG
$349B
$2.58M 0.26%
32,784
– –
PFE icon
35
Pfizer
PFE
$143B
$2.48M 0.25%
87,988
– –
MMM icon
36
3M
MMM
$83.4B
$2.26M 0.22%
18,849
– –
JNJ icon
37
Johnson & Johnson
JNJ
$609B
$2.15M 0.21%
20,579
– –
BMY icon
38
Bristol-Myers Squibb
BMY
$124B
$1.49M 0.15%
30,730
– –
EMR icon
39
Emerson Electric
EMR
$78.2B
$1.48M 0.15%
22,355
– –
IBM icon
40
IBM
IBM
$200B
$1.1M 0.11%
6,339
– –
ABBV icon
41
AbbVie
ABBV
$450B
$1.07M 0.11%
18,990
– –
ABT icon
42
Abbott
ABT
$175B
$777K 0.08%
18,990
– –
GSK icon
43
GSK
GSK
$104B
$730K 0.07%
10,925
– –
PEP icon
44
PepsiCo
PEP
$187B
$729K 0.07%
8,160
– –
XOM icon
45
ExxonMobil
XOM
$611B
$556K 0.06%
5,520
– –
ORCL icon
46
Oracle
ORCL
$364B
$358K 0.04%
8,837
– –
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$353K 0.04%
1,803
+106
+6% +$20.2K
CVX icon
48
Chevron
CVX
$373B
$330K 0.03%
2,528
– –
HUM icon
49
Humana
HUM
$48B
$275K 0.03%
2,150
– –
PGR icon
50
Progressive
PGR
$121B
$216K 0.02%
8,500
– –
1
2
3

Similar funds

BBNA
Bremer Bank National Association St Paul, Minnesota $562M AUM 9.12% 1-Year Est. Return
PAM
Pinpoint Asset Management Hong Kong $576M AUM 43.65% 1-Year Est. Return
FP
FPR Partners San Francisco, California $579M AUM 26.76% 1-Year Est. Return
MIS
Morningstar Investment Services Chicago, Illinois $546M AUM 8.26% 1-Year Est. Return
ACP
Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return
BMM
Buffington Mohr McNeal Boise, Idaho $507M AUM 5.85% 1-Year Est. Return
CF
Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return
CWC
Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return

Poplar Forest Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Poplar Forest Capital held 54 positions worth $1.01B, up 7.4% from $937M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Poplar Forest Capital's Q2 2014 filing shows 5 new, 23 increased, 8 reduced and 2 closed positions. Its largest new stake was Dun & Bradstreet: 99,688 shares worth $11M. The largest sale was Allergan plc, an estimated $13.5M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Technology and Energy.

  • Poplar Forest Capital's largest Q2 2014 buy was Dun & Bradstreet: 99,688 shares worth $11M.
  • Poplar Forest Capital added most to MetLife in Q2 2014, an estimated $11.6M increase.
  • Poplar Forest Capital's biggest Q2 2014 reduction was TE Connectivity, cutting an estimated $12M.
  • Poplar Forest Capital fully exited Allergan plc in Q2 2014, selling an estimated $13.5M.
  • Poplar Forest Capital's ten largest holdings make up 44% of its $1.01B portfolio in Q2 2014.
  • Poplar Forest Capital opened 5 new positions and closed 2 in Q2 2014.
  • Poplar Forest Capital's portfolio value rose 7.4% quarter-over-quarter to $1.01B.

Based on Poplar Forest Capital's 13F filing for Q2 2014, filed 12 Aug 2014.